Results 21 to 30 of about 599,797 (262)

Molecular mechanisms of severe acute respiratory syndrome (SARS) [PDF]

open access: yes, 2005
Severe acute respiratory syndrome (SARS) is a new infectious disease caused by a novel coronavirus that leads to deleterious pulmonary pathological features.
David A Groneberg   +6 more
core   +1 more source

In vitro and in vivo expression of foreign genes by transmissible gastroenteritis coronavirus-derived minigenomes [PDF]

open access: yes, 2002
A helper-dependent expression system based on transmissible gastroenteritis coronavirus (TGEV) has been developed using a minigenome of 3·9 kb (M39).
Enjuanes, L.   +11 more
core   +1 more source

Epidemiology of the first 100 cases of COVID-19 in Taiwan and its implications on outbreak control

open access: yesJournal of the Formosan Medical Association, 2020
Purpose: To describe the epidemiology and outcome of the first 100 COVID-19 cases in Taiwan. Methods: We included the first 100 patients with laboratory-confirmed SARS-CoV-2 infection in Taiwan.
Tsung-Pei Tsou   +20 more
doaj   +1 more source

Methods for estimating the case fatality ratio for a novel, emerging infectious disease. [PDF]

open access: yes, 2005
During the course of an epidemic of a potentially fatal disease, it is important that the case fatality ratio be well estimated. The authors propose a novel method for doing so based on the Kaplan-Meier survival procedure, jointly considering two ...
W. S. Chan   +21 more
core   +1 more source

Coronavirus Disease 2019 and Heart Failure: A Multiparametric Approach

open access: yesCardiac Failure Review, 2020
Coronavirus disease 2019 (COVID-19) is a debilitating viral infection and, to date, 628,903 people have died from it, numbers that cannot yet be compared to the 50 million who died in the 1918 flu pandemic.
Estefania Oliveros   +5 more
doaj   +1 more source

Analysis of Incidentally Diagnosed Patients with Coronavirus Disease 2019 at the Emergency Department: Single-Center Clinical Experience [PDF]

open access: yes, 2021
Objective: Asymptomatic patients with coronavirus disease 2019 can present with signs of various diseases to hospitals. We aimed to present patients who presented to the emergency department without any coronavirus disease 2019 symptoms and were ...
Erdal Tekin   +5 more
core   +1 more source

Human monoclonal antibody combination against SARS coronavirus : synergy and coverage of escape mutants [PDF]

open access: yes, 2006
Background: Experimental animal data show that protection against severe acute respiratory syndrome coronavirus (SARS-CoV) infection with human monoclonal antibodies (mAbs) is feasible.
Peiris, Joseph S. M.   +73 more
core   +1 more source

Coronavirus disease 2019 and cardiovascular disease

open access: yesTzu Chi Medical Journal, 2023
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus behind the coronavirus disease 2019 (COVID-19) pandemic, is a type of RNA virus that is nonsegmented. Cardiovascular diseases (CVDs) increase the mortality risk of patients.
Jenn-Yeu Song   +7 more
doaj   +1 more source

Comparative analysis of environmental persistence of SARS-CoV-2 variants and seasonal coronaviruses

open access: yesApplied and Environmental Microbiology
Conducting persistence studies of infectious severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on environmental surfaces may require a biosafety level 3 (BSL-3) laboratory. We aimed to compare the environmental persistence of BSL-2 level human
Geun Woo Park   +10 more
doaj   +1 more source

Association of infection-induced antibody levels with risk of subsequent SARS–COV-2 reinfection among healthcare professionals, Rhode Island, 1 March 2020–17 February 2021

open access: yesMicrobiology Spectrum
Numerous studies have investigated vaccine-induced correlates of protection (CoP) against severe acute respiratory syndrome–coronavirus 2 (SARS–CoV-2) infection, but data on infection-induced CoP are limited.
Jianrong Shi   +9 more
doaj   +1 more source

Home - About - Disclaimer - Privacy